FibroGen (FGEN) Misses Q4 EPS by 79c

FibroGen (NASDAQ: FGEN) reported Q4 EPS of ($1.45), $0.79 worse than the analyst estimate of ($0.66). Revenue for the quarter came in at $16.5 million versus the consensus estimate of $47.65 million.

For earnings history and earnings-related data on FibroGen (FGEN) click here.

You May Also Be Interested In

• Piper Sandler lists 5 chip stocks to buy
• Signet Jewelers (SIG) PT Raised to $136 at UBS on Strong Growth Prospects
• Oppenheimer Starts Aehr Test Systems (AEHR) at Outperform, 'AI Burn-In Inflection Underappreciated'